Healthcare >> Analyst Interviews >> January 25, 2010
Dr. Ashim Anand, Ph.D., is a diagnostics Analyst at Natixis Bleichroeder who exclusively focuses on this sector. He has worked in biotechnology and medical devices equity research both on the buy side and the sell side. Dr. Anand's medical background includes a stint as a scientist at Harvard Medical School, an entrepreneur endeavor (the founding of a private biotech firm), several consulting projects with large pharmaceutical companies, sales experience at Ranbaxy Pharmaceuticals and several peer-reviewed papers published in biomedical journals. He received an MBA in finance and accounting from Columbia Business School, a Ph.D. in molecular biology and biochemistry from UMDNJ/Rutgers. He also has a master's degree in biotechnology and a bachelor's degree in pharmacy from Sagar University. Profile
TWST: What do you cover within the medical services sector?
Dr. Anand: Officially I still cover medical devices stocks, but I focus on diagnostics. I focus on diagnostics per se without the
